About Macvally Pharma Private Limited
Data last updated:
Macvally Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74999WB2018PTC226906. Its GSTIN is 19AALCM9488L1ZB (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Chandan Singha Roy and Piya Singharoy.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 79B Dr. Lal Mohan Bhattacharjee Road Entally, Kolkata, West Bengal, India – 700014.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.1 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹51,500 (net margin 0.5%) and EBITDA of ₹7.65 Lakh (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 75% over three years.
As per MCA filings, the company has open charges of ₹9.9 Lakh on record.
For more details, the company can be reached via its website macvallypharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address79B Dr. Lal Mohan Bhattacharjee Road Entally, Kolkata, West Bengal, India – 700014
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Macvally Pharma Private Limited FY 2024 filings available
Macvally Pharma Private Limited reported revenue of ₹1.1 Cr (down 13% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Macvally Pharma Private Limited
Revenue fell 13% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 75%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Macvally Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹1.1 Cr | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.65 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹51,500 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Macvally Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 7% | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Macvally Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Macvally Pharma Private Limited
Macvally Pharma Private Limited is audited by DUTTA LAHIRI AND CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DUTTA LAHIRI AND CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Macvally Pharma Private Limited
Macvally Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Piya Singharoy | Additional Director | 01 Feb 2021 | 5 Years 8 Months | Current |
| Chandan Singha Roy | Director | 06 Jul 2018 | 8 Years 3 Months | Current |
Ownership and Shareholding of Macvally Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Macvally Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Nov 2022 | Others | ₹9.9 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Macvally Pharma Private Limited
Employment history and EPFO contributions of people linked to Macvally Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Macvally Pharma Private Limited
Macvally Pharma Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Darathi Kanjilal ceased to be Additional Director on 05 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Macvally Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Macvally Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Macvally Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Macvally Pharma Private Limited
Macvally Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AALCM9488L1ZB | West Bengal | Active | 27 Dec 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Macvally Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Macvally Pharma Private Limited
Macvally Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 July 2018 (8+ years old) and is registered under CIN U74999WB2018PTC226906.
Macvally Pharma reported revenue of ₹1.1 Cr for FY 2022 (down 13% YoY).
Macvally Pharma has 2 current directors:
- Piya Singharoy - Additional Director
- Chandan Singha Roy - Director
Macvally Pharma reported a net profit of ₹51,500 (net margin 0.5%) and EBITDA of ₹7.65 Lakh (EBITDA margin 7%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Macvally Pharma is 75% over three years. In the latest year (FY 2022) revenue fell 13%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Macvally Pharma is 19AALCM9488L1ZB, registered in West Bengal.
The CIN (Corporate Identification Number) of Macvally Pharma is U74999WB2018PTC226906. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Macvally Pharma was incorporated on 06 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kolkata.
Darathi Kanjilal ceased to be Additional Director on 05 Sep 2022. Piya Singharoy was appointed as Additional Director on 01 Feb 2021. Amitabha Chaudhuri ceased to be Managing Director on 22 Dec 2020. Macvally Pharma has 5 board changes on record in total.
Macvally Pharma can be reached through the website macvallypharma.com. Its registered office is in Kolkata, West Bengal, India.